Skip to main content
Log in

Interleukin-1β upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT)

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Human keratinocytes synthesize and secrete tissue-type plasminogen activator (tPA). tPA converts the inactive precursor enzyme plasminogen into the trypsin-like proteinase plasmin. tPA is not found in normal epidermis, but in lesional epidermis from patients with a variety of cutaneous diseases, including psoriasis, pemphigus and pemphigoid. The presence of tPA is probably a reaction to the disease process rather than the initiating event in these etiologically and histopathologically diverse lesions. However, the factor(s) that upregulate tPA expression and secretion in keratinocytes have remained largely elusive. We sought to determine whether the inflammatory cytokine interleukin-1β (IL-1β), which is commonly present in diverse epidermal lesions, influences tPA production. Accordingly, we studied the influence of IL-1β on secretion of tPA by cells of the human keratinocyte cell line HaCaT. We found that IL-1β increased tPA secretion in these cells. Given the observation that IL-1β is a common proinflammatory mediator in cutaneous diseases, our findings may explain the increase in tPA in clinically and etiologically diverse inflammatory epidermal lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baird J, Lazarus GS, Belin D, Vassalli J-D, Busso N, Gubler P, Jensen PJ (1990) mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548–552

    Article  PubMed  CAS  Google Scholar 

  2. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337:211–214

    Article  PubMed  CAS  Google Scholar 

  3. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY (1988) Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437–9442

    PubMed  CAS  Google Scholar 

  4. Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119–124

    Article  PubMed  CAS  Google Scholar 

  5. Boukamp P, Petrusevska RT, Breitkreuz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–771

    Article  PubMed  CAS  Google Scholar 

  6. Buessecker F, Reinartz J, Schirmer U, Kramer MD (1993) Enzyme-linked immunosorbent assays for plasminogen activators. J Immunol Methods 162:193–200

    Article  PubMed  CAS  Google Scholar 

  7. Buessecker F, Reinartz J, Kramer MD (1995) tPA of human keratinocytes: contribution to cell-surface-associated plasminogen activation and upregulation by retinoic acid. Exp Dermatol 4:357–364

    Article  PubMed  CAS  Google Scholar 

  8. Burge SM, Marshall JM, Cederholm-Williams SA (1992) Plasminogen binding sites in normal human skin. Br J Dermatol 126:35–41

    Article  PubMed  CAS  Google Scholar 

  9. Chomczynski P, Sacchi N (1986) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biocehm 162:156–159

    Article  Google Scholar 

  10. Danö K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1989) Plasminogen activators and cancer. Adv Cancer Res 1–225

  11. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652

    PubMed  CAS  Google Scholar 

  12. Dower SK, Qwarnstrom EE, Page RC, Blanton RA, Kupper TS, Raines E, Ross R, Sims JE (1990) Biology of the interleukin-1 receptor. J Invest Dermatol 94:68S-73S

    Article  PubMed  CAS  Google Scholar 

  13. Finlay GJ, Baguley BC, Wilson WR (1984) A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal Biochem 139:272–277

    Article  PubMed  CAS  Google Scholar 

  14. Friberger P (1982) Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikreinkinin systems. Scand J Clin Lab Invest 42 [Suppl 162]:1–98

    CAS  Google Scholar 

  15. Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest 76:1585–1591

    PubMed  CAS  Google Scholar 

  16. Gissler HM, Frank R, Kramer MD (1993) Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Br J Dermatol 128:612–618

    Article  PubMed  CAS  Google Scholar 

  17. Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA (1989) Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 125:925–930

    Article  PubMed  CAS  Google Scholar 

  18. Grondahl-Hansen J, Ralfkiaer E, Nielsen LS, Kristensen P, Frentz G, Danö K (1987) Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88:28–32

    Article  PubMed  CAS  Google Scholar 

  19. Harris TJR, Patel T, Marston FAP, Little S, Emtage JS, Opdenakker G, Volckaert G, Rombauts W, Billiau A, De Somer P (1986) Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli. Mol Biol Med 3:279–292

    PubMed  CAS  Google Scholar 

  20. Hashimoto K, Singer KH, Lide WB, Shafran K, Webber P, Morioka S, Lazarus GS (1983) Plasminogen activator in cultured human epidermal cells. J Invest Dermatol 81:424–429

    Article  PubMed  CAS  Google Scholar 

  21. Jensen P, John M, Baird J (1990) Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187:162–169

    Article  PubMed  CAS  Google Scholar 

  22. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS (1988) Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90:777–782

    Article  PubMed  CAS  Google Scholar 

  23. Jobling SA, Auron PE, Gurka G, Webb AC, McDonald B, Rosenwasser LJ, Gehrke L (1988) Biological activity and receptor binding of human prointerleukin-1 beta and subpeptides. J Biol Chem 263: 16372–16378

    PubMed  CAS  Google Scholar 

  24. Kapp A (1993) Die Rolle von Zytokinen für die Pathogenese der Psoriasis. Hautarzt 44:201–207

    PubMed  CAS  Google Scholar 

  25. Kramer MD, Reinartz J, Schaefer B (1995) Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol Chem Hoppe Seyler 376:131–141

    PubMed  CAS  Google Scholar 

  26. Kupper TS (1990) Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86: 1783–1789

    PubMed  CAS  Google Scholar 

  27. Kupper TS, Chua AO, Flood P, McGuire J, Gubler U (1987) Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 80: 430–436

    PubMed  CAS  Google Scholar 

  28. Mizutani H, Black R, Kupper TS (1991) Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. J Clin Invest 87:1066–1071

    Article  PubMed  CAS  Google Scholar 

  29. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991) Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821–825

    Article  PubMed  CAS  Google Scholar 

  30. Morioka S, Jensen PJ, Lazarus GS (1985) Human epidermal plasminogen activator. Characterization, localization, and modulation. Exp Cell Res 161:364–372

    Article  PubMed  CAS  Google Scholar 

  31. Prens EP, Benne K, Van Damme J, Bakkus M, Brakel K, Benner R, van Joost Th (1990) Interleukin-1 and Interleukin-6 in psoriasis. J Invest Dermatol 95:121S-124S

    Article  PubMed  CAS  Google Scholar 

  32. Reinartz J, Batrla R, Boukamp P, Fusenig N, Kramer MD (1993) Binding and activation of plasminogen at the surface of human keratinocytes. Exp Cell Res 208:197–208

    Article  PubMed  CAS  Google Scholar 

  33. Reinartz J, Näher H, May H, Kramer MD (1993) Plasminogen activation in lesional skin of pemphigus vulgaris typ Neumann. Arch Dermatol Res 284:432–439

    Article  PubMed  CAS  Google Scholar 

  34. Spiers EM, Lazarus GS, Lyons Giordano B (1994) Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102:333–338

    Article  PubMed  CAS  Google Scholar 

  35. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768–774

    Article  PubMed  CAS  Google Scholar 

  36. Vassalli J-D, Sappino A-P, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88:1067–1072

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rox, J.M., Reinartz, J. & Kramer, M.D. Interleukin-1β upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT). Arch Dermatol Res 288, 554–558 (1996). https://doi.org/10.1007/BF02505254

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02505254

Key words

Navigation